home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
  HUM-MOLGEN -> Events -> Courses and Workshops  
 

Positive and Negative Effects of Visible Light, on Skin and Elsewhere

 
  October 03, 2018  
     
 
CfPA-The Center for Professional Advancement, Online Live
January 9, 2019 at 11:00 a.m.–12:30 p.m. (ET)


Who Should Attend?
This course is intended for professionals in the cosmetics and personal care industry, sunscreens, topical pharmaceuticals and for dermatologists. It will be especially beneficial to those that specialize in:
  • Research and development
  • Formulations
  • Regulatory
  • Clinical assessment
  • Marketing 

Course Description
Visible light is the main component of solar radiation and is the primary cause of the greenhouse effect. Recent evidence suggests that High Energy Visible (HEV) light is harmful to skin and other evidences seem to point out a beneficial effect of longer wavelengths. With natural endogenous photosensitizers HEV light can generate comparable amounts of reactive oxygen species (ROS’s) when interacting with skin as those produced by UVA and UVB. Visible light is also used as a therapeutic wavelength in the clinic to alleviate skin conditions either directly or via photo-dynamic therapy treatments.

This 90-minute accredited training course will discuss a multidisciplinary overview involving biochemistry and photobiology. The role of visible light in modulating the inflammatory response and other phenomena such as healing, barrier recovery and melanogenesis will be discussed.

Can't Make this LIVE Webinar? 
Simply select the On Demand option when registering and we will send you the link to view the recorded version.

This course will be available On Demand: January 10, 2019
 
 
Organized by: CfPA-The Center for Professional Advancement
Invited Speakers:
   Paolo Giacomoni, Ph.D., Consultant to the Skin Care Industry

Dr. Paolo Giacomoni (Insight Analysis Consulting, Madison, AL), is an independent consultant to the Skin Care Industry. He served as Chief Scientific Officer with Elan Rose International (2015-2018) and as VP of Skin Care Worldwide R&D with Herbalife (2011-2014) where he has been responsible for preparing new Skin Care lines.

Dr Giacomoni is a quality - focused leader with over 20 years experience in product research and development for cosmetic products provider. 

Previously, Dr. Giacomoni was with Estée Lauder as their Executive Director of Research. During that time he was in charge of research and communications for Clinique and interacted frequently with beauty editors. He was also in charge of meeting with suppliers of raw materials and he understands from both sides, the negotiation process to enter a raw material in a skin care product. He contributed research on cell and surface biochemistry for best-selling products such as Youth Surge, Turnaround Concentrate, Anti-Gravity, UV-Response, Superdefense, Even Better, Laser Focus, and Repairwear Night/Day. 

During his tenure at L’Oréal as Head of the Department of Biology and then as scientific attaché to the Director of Applied Research, he built a distinguished record of achievement through research on DNA damage and metabolic impairment induced by UV, and on the positive effects of antioxidants. His action lead to testing and integrating new technologies as part of the product development processes of best selling products such as Lancôme’s Rénergie and Primordial. While with L’ Oréal, he was a founder of the European Society for Photobiology and of the European Network for the Study of the Biology of Aging. During his Academic years he was Maître de Conférences at the University of Paris, France, and Visiting Professor at the University of Milano, Italy. 

Dr. Giacomoni is fluent in French, Italian, German, Spanish and English and is the author of 100+ publications and patents representing breakthrough industry concepts. He received his Ph.D., in Biochemistry from Université Paris VI, Paris France; his Masters Degree in Atomic Physics from Università di Milano, Milano, Italy and had Post-Doctoral Training at Deutsches Krebsforschungszentrum, Heidelberg, Germany, at University of Wisconsin, Madison, WI and at University of California, San Diego, CA.
 
Deadline for Abstracts: n/a
 
Registration: Please click here for registration information.
E-mail: jmorbit@cfpa.com
 
   
 
home   genetic news   bioinformatics   biotechnology   literature   journals   ethics   positions   events   sitemap
 
 
 

Generated by meetings and positions 5.0 by Kai Garlipp
WWW: Kai Garlipp, Frank S. Zollmann.
7.0 © 1995- HUM-MOLGEN. All rights reserved. Liability, Copyright and Imprint.